CoChat

Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study

Dahlqvist, Sofia, Rosengren, Annika, Gudbjörnsdottir, Soffia, Pivodic, Aldina, Wedel, Hans, Kosiborod, Mikhail, Svensson, Ann-Marie, Lind, Marcus · 2017 · The Lancet Diabetes & Endocrinology

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

Background Type 1 diabetes is associated with an increased risk of developing several cardiovascular complications. To our knowledge, the independent association between type 1 diabetes and atrial fibrillation has not been studied.Methods We did a prospective case-control study of individuals with type 1 diabetes in the Swedish National Diabetes Registry who were each matched with five controls for age, sex, and county of residence who were randomly selected from the Swedish Population Register. Cases of atrial fibrillation were obtained from the Swedish National Patient Registry.Findings We followed up 36 258 patients with type 1 diabetes and 179 980 controls between Jan 1, 2001, and Dec 31, 2013. Median follow-up was 9·7 years (IQR 5·2-13·0) for patients and 10·2 years (5·7-13·0) for controls. 749 (2%) individuals with type 1 diabetes and 2882 (2%) controls were diagnosed with atrial fibrillation, with an adjusted hazard ratio (HR) of 1·13 (95% CI 1·01-1·25; p=0·029) in men and 1·50 (1·30-1·72; p<0·0001) in women (p=0·0019 for interaction). The excess risk of atrial fibrillation in individuals with type 1 diabetes increased with worsening glycaemic control and renal complications. Among individuals with normoalbuminuria, no excess risk of atrial fibrillation was noted in men with type 1 diabetes who had HbA 1c lower than 9·7% (<83 mmol/mol) or in women with type 1 diabetes who had HbA 1c lower than 8·8% (<73 mmol/mol).Interpretation Compared with the general population, the risk of atrial fibrillation in men with type 1 diabetes was slightly raised, whereas for female patients it was 50% higher. The risk of atrial fibrillation in people with type 1 diabetes increased with renal complications and poor glycaemic control.Funding Novo Nordisk Foundation, Swedish State (ALF agreement), Swedish Research Council (SIMSAM), Swedish Heart and Lung Foundation, Swedish Diabetes Foundation, Diabetes Wellness.

Overview

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(17)30262-0

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 33 references

Cited by

See all 70

Metadata

Authors
Dahlqvist, S., Rosengren, A., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Kosiborod, M., Svensson, A.-M., & Lind, M.
Affiliations
  • NU Hospital Group (SE)
  • Sahlgrenska University Hospital (SE)
  • University of Gothenburg (SE)
  • Saint Luke's Hospital (US)
  • Region Västra Götaland (SE)
Corresponding author
Lind, Marcus
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2017-10
Volume
5
Issue
10
Pages
799-807
ISSN
2213-8587 (ISSN-L)
OpenAlex
W2750016484
Cited by
70
References
33
Citations by year
2026: 2 · 2025: 6 · 2024: 6 · 2023: 5 · 2022: 12 · 2021: 8 · 2020: 12 · 2019: 5 · 2018: 10 · 2017: 4
FWCI
6.55
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Diabetes & Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Hjärt-Lungfonden
  • Novo Nordisk
  • Novo Nordisk Fonden (NNF15OC0015260)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
type 1 diabetes, atrial fibrillation, cardiovascular risk, glycemic control, HbA1c, diabetic nephropathy, albuminuria, sex differences, renal complications
MeSH terms
Adolescent, Adult, Aged, Atrial Fibrillation, Diabetes Mellitus, Type 1, Female, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Case-Control Studies, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study. https://app.cochat.ai/papers/10.1016/s2213-8587(17)30262-0
The paper
Dahlqvist, S., Rosengren, A., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Kosiborod, M., Svensson, A.-M., & Lind, M. (2017). Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study. The Lancet Diabetes & Endocrinology. https://doi.org/10.1016/s2213-8587(17)30262-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.